Board of Directors At present, the Board of Directors of Exiqon A/S is composed of four members. The Board members’ business address is Exiqon A/S, Skelstedet 16, 2950 Vedbæk, Denmark.
A list of the members of the Board of Directors is set out below.
Erik Walldén, chairman (elected to the Board in May 2007) (Swedish citizen). Erik Walldén, Chairman and President of WalldenAssociates (Erik Wallden AB), and Chairman of the Board at Arocell AB and Genovis AB, has a record of achievement in the biotech industry for over 30 years. He has held senior management positions in companies such as Pharmacia LKB Biotechnology AB and PerSeptive Biosystems Inc. Erik Walldén was formerly the CEO of Pyrosequencing AB, Biacore International AB, Affibody Holding AB and Gyros AB.
Thorleif Krarup, vice chairman (elected to the Board in May 2007) (Danish citizen). Thorleif Krarup holds a number of directorships and is Senior Advisor to a number of international financial institutions. During the period 1985-2003, Thorleif Krarup served as Managing Director/Group CEO in Nykredit (1985-1992), Unibank (1992-2000) and Nordea (2000-2003).
Michael Nobel, board member (elected to the Board in January 1996) (Danish citizen). Michael Nobel was trained and employed with A.P.Møller between 1978 and 1983, after which time he became Export Manager with E. Nobel Cigar og Tobaksfabrikker A/S and Skandinavisk Tobakskompagni A/S.
Per Wold-Olsen, board member (elected to the Board in April 2008) (Norwegian citizen). Per Wold-Olsen, MBA, was CEO of MSD Norway from 1976 to 1986 when he was appointed Regional Director and VP of MSD Scandinavia. In 1991, Per Wold-Olsen was appointed Senior Vice President for Worldwide Human Health Marketing of Merck & Co., Inc., U.S., and in 1994 he was appointed President for Human Health Europe Merck & Co., Inc., U.S. In 1997, his responsibilities for Human Health Europe were extended to include Eastern Europe, the Middle East and Africa, and Worldwide Human Health Marketing. In 2005, his field of responsibility was extended to include Latin America and Canada as President for Human Health Intercontinental Region, Merck & Co., Inc. From 1994 to 2006, Per Wold-Olsen was a member of Merck’s Management Committee.
Rodney Turner, board member (elected to the Board in March 2015) (American citizen). Rodney Turner is a board member of AYOXXA Biosystems GmbH and former Vice President, Corporate Business Development, at Life Technologies Corporation from 2006 to 2014. He has previously served with RTK Group, Inc. from 2002 to 2006, and before that with Fluidigm Corporation (2001-2003) and EVOTEC OAI AG, Hamburg, Germany (1995-2001).